Dashyant Dhanak, EVP & Chief Scientific Officer at INCYTE CORP (INCY), sold 389 shares at $68.67 ($27K) on 2021-10-01, disclosed to the SEC on 2021-10-04.
Scheduled sale ($27k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| INCY | SELL | 2021-08-04 | $30K | — | Filing → |
| INCY | SELL | 2021-07-02 | $33K | — | Filing → |
| INCY | SELL | 2021-06-14 | $335K | — | Filing → |